Cargando…
Clinical and echocardiographic trends in percutaneous balloon mitral valvuloplasty
BACKGROUND: The prevalence of Rheumatic Mitral Stenosis (MS) has significantly changed over the last decades. We intend to examine patient demographics, Echocardiographic characteristics, procedural success rates, and complications throughout 30-years. METHODS: We conducted a single-center descripti...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017687/ https://www.ncbi.nlm.nih.gov/pubmed/33794935 http://dx.doi.org/10.1186/s13019-021-01442-w |
_version_ | 1783674098270863360 |
---|---|
author | Koren, Ofir Israeli, Asaf Rozner, Ehud Darawshy, Nassem Turgeman, Yoav |
author_facet | Koren, Ofir Israeli, Asaf Rozner, Ehud Darawshy, Nassem Turgeman, Yoav |
author_sort | Koren, Ofir |
collection | PubMed |
description | BACKGROUND: The prevalence of Rheumatic Mitral Stenosis (MS) has significantly changed over the last decades. We intend to examine patient demographics, Echocardiographic characteristics, procedural success rates, and complications throughout 30-years. METHODS: We conducted a single-center descriptive observational study. The study population consists of patients undergone percutaneous balloon mitral valvuloplasty (PBMV) at Emek Medical Center in Israel from January 1990 to May 2019. RESULTS: Four hundred seventeen patients underwent PBMV during the study period and were eligible for the study. Age did not change significantly over time (p = 0.09). The prevalence of Male and patients who were smoking and had multiple comorbidities such as hypertension, dyslipidemia, ischemic heart disease, and chronic kidney disease became increases over time (p = 0.02, p = 0.02, p = 0.001, p = 0.01, p = 0.02, and p = 0.001, respectively). Wilkins score and all its components increased over time, and the total score was higher in females (p = 0.01). Seventy-nine (18.9%) patients had complications. The rate of complications did not change over decades. Patients with Wilkins score > 8, post-procedural MR of ≥2, and post-procedural MVA < 1.5 had the highest risk for the need of Mitral valve replacement (MVR) surgery in 2 years following PBMV (3.64, 4.03, 2.44, respectively, CI 95%, p < .0001 for all). The median time in these patients was 630 days compared to 4–5 years in the entire population. Patients with Post-procedural MR of ≥2 and post-procedural MVA < 1.5 had ten times risk for developing heart failure (HR 9.07 and 10.06, respectively, CI 95%, P < .0001). CONCLUSION: Our research reveals trends over time in patients’ characteristics and echocardiographic features. Our study population consists of more male patients with multiple comorbidities and more complex and calcified valvular structures in the last decade. Wilkins score > 8, post-procedural MR of ≥2, and post-procedural MVA < 1.5 cm(2) were in-depended predictors for the time for surgery and heart failure hospitalization. |
format | Online Article Text |
id | pubmed-8017687 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-80176872021-04-02 Clinical and echocardiographic trends in percutaneous balloon mitral valvuloplasty Koren, Ofir Israeli, Asaf Rozner, Ehud Darawshy, Nassem Turgeman, Yoav J Cardiothorac Surg Research Article BACKGROUND: The prevalence of Rheumatic Mitral Stenosis (MS) has significantly changed over the last decades. We intend to examine patient demographics, Echocardiographic characteristics, procedural success rates, and complications throughout 30-years. METHODS: We conducted a single-center descriptive observational study. The study population consists of patients undergone percutaneous balloon mitral valvuloplasty (PBMV) at Emek Medical Center in Israel from January 1990 to May 2019. RESULTS: Four hundred seventeen patients underwent PBMV during the study period and were eligible for the study. Age did not change significantly over time (p = 0.09). The prevalence of Male and patients who were smoking and had multiple comorbidities such as hypertension, dyslipidemia, ischemic heart disease, and chronic kidney disease became increases over time (p = 0.02, p = 0.02, p = 0.001, p = 0.01, p = 0.02, and p = 0.001, respectively). Wilkins score and all its components increased over time, and the total score was higher in females (p = 0.01). Seventy-nine (18.9%) patients had complications. The rate of complications did not change over decades. Patients with Wilkins score > 8, post-procedural MR of ≥2, and post-procedural MVA < 1.5 had the highest risk for the need of Mitral valve replacement (MVR) surgery in 2 years following PBMV (3.64, 4.03, 2.44, respectively, CI 95%, p < .0001 for all). The median time in these patients was 630 days compared to 4–5 years in the entire population. Patients with Post-procedural MR of ≥2 and post-procedural MVA < 1.5 had ten times risk for developing heart failure (HR 9.07 and 10.06, respectively, CI 95%, P < .0001). CONCLUSION: Our research reveals trends over time in patients’ characteristics and echocardiographic features. Our study population consists of more male patients with multiple comorbidities and more complex and calcified valvular structures in the last decade. Wilkins score > 8, post-procedural MR of ≥2, and post-procedural MVA < 1.5 cm(2) were in-depended predictors for the time for surgery and heart failure hospitalization. BioMed Central 2021-04-01 /pmc/articles/PMC8017687/ /pubmed/33794935 http://dx.doi.org/10.1186/s13019-021-01442-w Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Koren, Ofir Israeli, Asaf Rozner, Ehud Darawshy, Nassem Turgeman, Yoav Clinical and echocardiographic trends in percutaneous balloon mitral valvuloplasty |
title | Clinical and echocardiographic trends in percutaneous balloon mitral valvuloplasty |
title_full | Clinical and echocardiographic trends in percutaneous balloon mitral valvuloplasty |
title_fullStr | Clinical and echocardiographic trends in percutaneous balloon mitral valvuloplasty |
title_full_unstemmed | Clinical and echocardiographic trends in percutaneous balloon mitral valvuloplasty |
title_short | Clinical and echocardiographic trends in percutaneous balloon mitral valvuloplasty |
title_sort | clinical and echocardiographic trends in percutaneous balloon mitral valvuloplasty |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017687/ https://www.ncbi.nlm.nih.gov/pubmed/33794935 http://dx.doi.org/10.1186/s13019-021-01442-w |
work_keys_str_mv | AT korenofir clinicalandechocardiographictrendsinpercutaneousballoonmitralvalvuloplasty AT israeliasaf clinicalandechocardiographictrendsinpercutaneousballoonmitralvalvuloplasty AT roznerehud clinicalandechocardiographictrendsinpercutaneousballoonmitralvalvuloplasty AT darawshynassem clinicalandechocardiographictrendsinpercutaneousballoonmitralvalvuloplasty AT turgemanyoav clinicalandechocardiographictrendsinpercutaneousballoonmitralvalvuloplasty |